Christoph Antz, PhD EIPL European Institute for Pharma Logistics GmbH

Dr. Christoph Antz is an experienced entrepreneur, company excecutive and venture capital manager in the fields of life sciences with special focus on drug and diagnostics development under GxP considerations in preclinical and clinical pharmacology.

He currently holds the CEO position at Acousia Therapeutics GmbH, Tübingen, Germany, one of the few companies worldwide focused on the development of Oto-Protective and Oto-Regenerative Drugs.

Before joining EIPL, he served as CEO and Managing Director of companies like Otogene AG, EMBL Ventures GmbH, Elara Pharmaceuticals GmbH, Abeta GmbH and Luxendo GmbH from founding up to successful M&A.

He holds a Ph.D. in Physics from the University of Heidelberg and did postdocteral studies at the University Of California, San Francisco. Christoph is an alumni of the Max-Planck-Institute For Medical Research, Heidelberg.